Serum Institute of India launches Rabishield, developed in partnership with UMMS
The Serum Institute of India announced the global launch of a rabies monoclonal antibody developed in partnership with UMass Medical School. Rabishield, a U.S.-patented product, will help close the gaps in rabies prevention and is expected to reduce the rabies mortality rate in India.
UMass Medical School announces The Li Weibo (李伟波) Institute for Rare Diseases Research
A new institute for rare diseases research at UMass Medical School will build on the school’s already substantial accomplishments in the fields of gene therapy, RNA biology and RNAi technology to accelerate the development of novel therapeutics for a host of disorders.
U.S. Rep. Jim McGovern, Worcester leaders support critical NIH funding for UMass Medical School
President Donald Trump’s proposal to cut 22 percent from the FY18 National Institutes of Health budget would cost UMass Medical School from $45 million to $74 million a year, Chancellor Michael F. Collins said at an Aug. 16 panel discussion on NIH funding at UMMS.